Revealing the truth of human disease. Protein by protein.

By : Jamal Fakir, Aurélie Mouka and Pasquale Cutolo (Société Olink)

Date : Monday 11 September 2023

4:00 PM - 5:00 PM

Place : Amphi Gustave Roussy

The Olink team will be delighted to present their unique technology called Proximity Extension Assay (PEA), an elegant combination of immunoreactions and molecular biology, enabling the reliable and non-invasive detection of 5300+ circulating protein biomarkers per sample (1 to 6 µl).

Olink panels have already been named in more than 1,300 publications and in numerous clinical trials. They are used for the identification of prognostic or predictive biomarkers, new and causal drug targets, or the early detection of diseases and their progression.

More generally, this technology provides a better understanding of the biology of diseases across a wide range of pathologies and fields of application (immunology, oncology, immuno-oncology, neurology, inflammatory, cardiovascular, metabolic and infectious diseases, wellness studies, population studies…).

During this presentation, the team will introduce you with the Olink technology and portfolio and will describe the Olink Biomarker strategies with a selection of publications to illustrate the different applications that PEA offers in your areas of expertise.

The Olink team is looking forward to meeting you and discussing with you how Olink’s PEA technology can bring new perspectives to your research projects and clinical trials.

The Olink Proteomics France team

All seminars